What Happened?
Bedford, MA-based Kaleido Biosciences Appointed Stephen Sofen as Senior Vice President of Technical Operation
About the Company
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s natural roles in promoting health.
About the Person
Stephen Sofen is Senior Vice President of Technical Operation at Kaleido Biosciences. Previously, Stephen held various senior IT leadership roles in the industry.
Info Source
News
Short Profile